The etiopathogenesis of obsessive-compulsive disorder (OCD) remains elusive. Clinical observation of the elevated frequency of obsessive-compulsive symptoms in patients with rheumatic fever, a post-streptococcal autoimmune disease, prompted the study of immune parameters in OCD. Anti-basal ganglia antibodies have been described in a subset of OCD patients. The assessment of circulating cytokines and immune cells confirmed unequivocal changes in at least some patients, although it is difficult to establish a particular immune profile in OCD. Several factors, including the use of psychotropic drugs and the presence of comorbid conditions, seem to influence these immune parameters.

Journal Section:
Editor's choice
Keywords:
Obsessive-compulsive disorder, Anti-basal ganglia antibodies, Rheumatic chorea
1.
Abramowitz JS, Taylor S, McKay D: Obsessive-compulsive disorder. Lancet 2009;374:491-499.
[PubMed]
https://doi.org/10.1016/S0140-6736(09)60240-3
2.
Murphy DL, Timpano KR, Wheaton MG, Greenberg BD, Miguel EC: Obsessive-compulsive disorder and its related disorders: a reappraisal of obsessive-compulsive spectrum concepts. Dialogues Clin Neurosci 2010;12:131-148.
[PubMed]
3.
Miguel EC, Leckman JF, Rauch S, Rosario-Campos MC, Hounie AG, Mercadante MT, Chacon P, Pauls DL: Obsessive-compulsive disorder phenotypes: implications for genetic studies. Mol Psychiatry 2005;10:258-275.
[PubMed]
https://doi.org/10.1038/sj.mp.4001617
4.
Stein DJ, Fineberg NA, Bienvenu OJ, Denys D, Lochner C, Nestadt G, Leckman JF, Rauch SL, Phillips KA: Should OCD be classified as an anxiety disorder in DSM-V? Depress Anxiety 2010;27:495-506.
[PubMed]
https://doi.org/10.1002/da.20699
5.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Washington, American Psychiatric Association, 2013.
6.
Rudin E: On the problem of compulsive disease with special reference to its hereditary relations (in undetermined language). Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr 1953;191:14-54.
[PubMed]
7.
Fontenelle LF, Hasler G: The analytical epidemiology of obsessive-compulsive disorder: risk factors and correlates. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1-15.
[PubMed]
https://doi.org/10.1016/j.pnpbp.2007.06.024
8.
Taylor S: Molecular genetics of obsessive-compulsive disorder: a comprehensive meta-analysis of genetic association studies. Mol Psychiatry 2013;18:799-805.
[PubMed]
https://doi.org/10.1038/mp.2012.76
9.
Stewart SE, Yu D, Scharf JM, Neale BM, Fagerness JA, Mathews CA, et al: Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry 2013;18:788-798.
[PubMed]
https://doi.org/10.1038/mp.2012.85
10.
Harrison BJ, Soriano-Mas C, Pujol J, Ortiz H, Lopez-Sola M, Hernandez-Ribas R, Deus J, Alonso P, Yucel M, Pantelis C, Menchon JM, Cardoner N: Altered corticostriatal functional connectivity in obsessive-compulsive disorder. Arch Gen Psychiatry 2009;66:1189-1200.
[PubMed]
https://doi.org/10.1001/archgenpsychiatry.2009.152
11.
Greenberg BD, Rauch SL, Haber SN: Invasive circuitry-based neurotherapeutics: stereotactic ablation and deep brain stimulation for OCD. Neuropsychopharmacology 2010;35:317-336.
[PubMed]
https://doi.org/10.1038/npp.2009.128
12.
Fontenelle LF, Harrison BJ, Yücel M, Pujol J, Fujiwara H, Pantelis C: Is there evidence of brain white-matter abnormalities in obsessive-compulsive disorder? A narrative review. Top Magn Reson Imaging 2009;20:291-298.
[PubMed]
https://doi.org/10.1097/RMR.0b013e3181e8f22c
13.
Walterfang M, Evans A, Looi JC, Jung HH, Danek A, Walker RH, Velakoulis D: The neuropsychiatry of neuroacanthocytosis syndromes. Neurosci Biobehav Rev 2011;35:1275-1283.
[PubMed]
https://doi.org/10.1016/j.neubiorev.2011.01.001
14.
Swedo SE, Rapoport JL, Cheslow DL, Leonard HL, Ayoub EM, Hosier DM, Wald ER: High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea. Am J Psychiatry 1989;146:246-249.
[PubMed]
15.
Teixeira AL, Maia DP, Cardoso F: UFMG Sydenham's chorea rating scale (USCRS): reliability and consistency. Mov Disord 2005;20:585-591.
[PubMed]
https://doi.org/10.1002/mds.20377
16.
Alvarenga PG, Hounie AG, Mercadante MT, Diniz JB, Salem M, Spina G, Miguel EC: Obsessive-compulsive symptoms in heart disease patients with and without history of rheumatic fever. J Neuropsychiatry Clin Neurosci 2006;18:405-408.
[PubMed]
17.
Hounie AG, Pauls DL, Mercadante MT, Rosário-Campos MC, Shavitt RG, de Mathis MA, de Alvarenga PG, Cúri M, Miguel EC: Obsessive-compulsive spectrum disorders in rheumatic fever with and without Sydenham's chorea. J Clin Psychiatry 2004;65:994-999.
[PubMed]
18.
Alvarenga PG, Floresi AC, Torres AR, Hounie AG, Fossaluza V, Gentil AF, Pereira CA, Miguel EC: Higher prevalence of obsessive-compulsive spectrum disorders in rheumatic fever. Gen Hosp Psychiatry 2009;31:178-180.
[PubMed]
https://doi.org/10.1016/j.genhosppsych.2008.11.003
19.
Colony HS, Malamud N: Sydenham's chorea: a clinicopathologic study. Neurology 1956;6:672-676.
[PubMed]
https://doi.org/10.1212/WNL.6.9.672
20.
Giedd JN, Rapoport JL, Kruesi MJ, Parker C, Schapiro MB, Allen AJ, Leonard HL, Kaysen D, Dickstein DP, Marsh WL, et al: Sydenham's chorea: magnetic resonance imaging of the basal ganglia. Neurology 1995;45:2199-2202.
[PubMed]
https://doi.org/10.1212/WNL.45.12.2199
21.
Rose NR, Bona C: Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993;14:426-430.
[PubMed]
https://doi.org/10.1016/0167-5699(93)90244-F
22.
Brimberg L, Benhar I, Mascaro-Blanco A, Alvarez K, Lotan D, Winter C, Klein J, Moses AE, Somnier FE, Leckman JF, Swedo SE, Cunningham MW, Joel D: Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders. Neuropsychopharmacology 2012;37:2076-2087.
[PubMed]
https://doi.org/10.1038/npp.2012.56
23.
Teixeira AL, Guimarães MM, Romano-Silva MA, Cardoso F: Serum from Sydenham's chorea patients modifies intracellular calcium levels in PC12 cells by a complement-independent mechanism. Mov Disord 2005;20:843-845.
[PubMed]
https://doi.org/10.1002/mds.20418
24.
Kirvan CA, Swedo SE, Heuser JS, Cunningham MW: Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 2003;9:914-920.
[PubMed]
https://doi.org/10.1038/nm892
25.
Kirvan CA, Cox CJ, Swedo SE, Cunningham MW: Tubulin is a neuronal target of autoantibodies in Sydenham's chorea. J Immunol 2007;178:7412-7421.
[PubMed]
26.
Hounie AG, Pauls DL, do Rosario-Campos MC, Mercadante MT, Diniz JB, De Mathis MA, De Mathis ME, Chacon P, Shavitt RG, Curi M, Guilherme L, Miguel EC: Obsessive-compulsive spectrum disorders and rheumatic fever: a family study. Biol Psychiatry 2007;61:266-272.
[PubMed]
https://doi.org/10.1016/j.biopsych.2006.02.021
27.
Seixas AA, Hounie AG, Fossaluza V, Curi M, Alvarenga PG, De Mathis MA, De Mathis ME, Vallada H, Pauls D, de Bragança Pereira CA, Miguel EC: Anxiety disorders and rheumatic fever: is there an association? CNS Spectr 2008;13:1039-1046.
[PubMed]
28.
Ramasawmy R, Faé KC, Spina G, Victora GD, Tanaka AC, Palácios SA, Hounie AG, Miguel EC, Oshiro SE, Goldberg AC, Kalil J, Guilherme L: Association of polymorphisms within the promoter region of the tumor necrosis factor-α with clinical outcomes of rheumatic fever. Mol Immunol 2007;44:1873-1878.
[PubMed]
https://doi.org/10.1016/j.molimm.2006.10.001
29.
Hounie AG, Cappi C, Cordeiro Q, Sampaio AS, Moraes I, Rosário MC, Palácios SA, Goldberg AC, Vallada HP, Machado-Lima A, Nakano E, Kalil J, Pauls D, Pereira CA, Guilherme L, Miguel EC: TNF-α polymorphisms are associated with obsessive-compulsive disorder. Neurosci Lett 2008;442:86- 90.
[PubMed]
https://doi.org/10.1016/j.neulet.2008.07.022
30.
Kurlan R, Johnson D, Kaplan EL, Tourette Syndrome Study Group: Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: a prospective blinded cohort study. Pediatrics 2008;121:1188-1197.
[PubMed]
https://doi.org/10.1542/peds.2007-2657
31.
Dale RC: Immune-mediated extrapyramidal movement disorders, including Sydenham chorea. Handb Clin Neurol 2013;112:1235-1241.
[PubMed]
https://doi.org/10.1016/B978-0-444-52910-7.00046-5
32.
Rocha FF, Correa H, Teixeira AL: Obsessive-compulsive disorder and immunology: a review. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1139-1146.
[PubMed]
https://doi.org/10.1016/j.pnpbp.2007.12.026
33.
Maina G, Albert U, Bogetto F, Borghese C, Berro AC, Mutani R, Rossi F, Vigliani MC: Anti-brain antibodies in adult patients with obsessive-compulsive disorder. J Affect Disord 2009;116:192-200.
[PubMed]
https://doi.org/10.1016/j.jad.2008.11.019
34.
Nicholson TR, Ferdinando S, Krishnaiah RB, Anhoury S, Lennox BR, Mataix-Cols D, Cleare A, Veale DM, Drummond LM, Fineberg NA, Church AJ, Giovannoni G, Heyman I: Prevalence of anti-basal ganglia antibodies in adult obsessive-compulsive disorder: cross-sectional study. Br J Psychiatry 2012;200:381-386.
[PubMed]
https://doi.org/10.1192/bjp.bp.111.092007
35.
Bhattacharyya S, Khanna S, Chakrabarty K, Mahadevan A, Christopher R, Shankar SK: Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder. Neuropsychopharmacology 2009;34:2489-2496.
[PubMed]
https://doi.org/10.1038/npp.2009.77
36.
Fabiani S, Pinto B, Bruschi F: Toxoplasmosis and neuropsychiatric diseases: can serological studies establish a clear relationship? Neurol Sci 2013;34:417-425.
[PubMed]
https://doi.org/10.1007/s10072-012-1197-4
37.
Miman O, Mutlu EA, Ozcan O, Atambay M, Karlidag R, Unal S: Is there any role of Toxoplasma gondii in the etiology of obsessive-compulsive disorder? Psychiatry Res 2010;177:263-265.
[PubMed]
https://doi.org/10.1016/j.psychres.2009.12.013
38.
Dietrich DE, Zhang Y, Bode L, Münte TF, Hauser U, Schmorl P, Richter-Witte C, Gödecke-Koch T, Feutl S, Schramm J, Ludwig H, Johannes S, Emrich HM: Brain potential amplitude varies as a function of Borna disease virus-specific immune complexes in obsessive-compulsive disorder. Mol Psychiatry 2005;10:519-520.
[PubMed]
https://doi.org/10.1038/sj.mp.4001688
39.
Rotge JY, Aouizerate B, Tignol J, Bioulac B, Burbaud P, Guehl D: The glutamate-based genetic immune hypothesis in obsessive-compulsive disorder: an integrative approach from genes to symptoms. Neuroscience 2010;165:408-417.
[PubMed]
https://doi.org/10.1016/j.neuroscience.2009.10.043
40.
Gray SM, Bloch MH: Systematic review of proinflammatory cytokines in obsessive-compulsive disorder. Curr Psychiatry Rep 2012;14:220-228.
[PubMed]
https://doi.org/10.1007/s11920-012-0272-0
41.
Mason JL, Suzuki K, Chaplin DD, Matsushima GK: Interleukin-1β promotes repair of the CNS. J Neurosci 2001;21:7046-7052.
[PubMed]
42.
Lopez KC, Lalonde F, Mattai A, Wade B, Clasen L, Rapoport J, Giedd JN: Quantitative morphology of the corpus callosum in obsessive-compulsive disorder. Psychiatry Res 2013;212:1-6.
[PubMed]
https://doi.org/10.1016/j.pscychresns.2012.10.012
43.
Fontenelle LF, Barbosa IG, Luna JV, de Sousa LP, Abreu MN, Teixeira AL: A cytokine study of adult patients with obsessive-compulsive disorder. Compr Psychiatry 2012;53:797-804.
[PubMed]
https://doi.org/10.1016/j.comppsych.2011.12.007
44.
Scalzo P, Kummer A, Cardoso F, Teixeira AL: Increased serum levels of soluble tumor necrosis factor-α receptor-1 in patients with Parkinson's disease. J Neuroimmunol 2009;216:122-125.
[PubMed]
https://doi.org/10.1016/j.jneuroim.2009.08.001
45.
Murphy ML, Pichichero ME: Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Arch Pediatr Adolesc Med 2002;156:356-361.
[PubMed]
https://doi.org/10.1001/archpedi.156.4.356
46.
Mittleman BB, Castellanos FX, Jacobsen LK, Rapoport JL, Swedo SE, Shearer GM: Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. J Immunol 1997;159:2994-2999.
[PubMed]
47.
Carpenter LL, Heninger GR, McDougle CJ, Tyrka AR, Epperson CN, Price LH: Cerebrospinal fluid interleukin-6 in obsessive-compulsive disorder and trichotillomania. Psychiatry Res 2002;112:257-262.
[PubMed]
https://doi.org/10.1016/S0165-1781(02)00233-0
48.
Marazziti D, Mungai F, Masala I, Baroni S, Vivarelli L, Ambrogi F, Catena Dell'Osso M, Consoli G, Massimetti G, Dell'Osso L: Normalisation of immune cell imbalance after pharmacological treatments of patients suffering from obsessive-compulsive disorder. J Psychopharmacol 2009;23:567-573.
[PubMed]
https://doi.org/10.1177/0269881108089605
49.
Marazziti D, Presta S, Pfanner C, Gemignani A, Rossi A, Sbrana S, Rocchi V, Ambrogi F, Cassano GB: Immunological alterations in adult obsessive-compulsive disorder. Biol Psychiatry 1999;46:810-814.
[PubMed]
https://doi.org/10.1016/S0006-3223(98)00371-0
© 2014 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2014
You do not currently have access to this content.